Archives by Month:

Archives by Year:

TIPping Points?

TIPping Points?

The Federal Reserve’s complete change last year wasn’t something that happened all at once. There were several hints that a lot was going on behind the scenes that may never become public, including five years (now four) down the road when the full policy transcripts are released to the public. There was more interest in […]
Stocks Rally On Fiscal Policy Progress

Stocks Rally On Fiscal Policy Progress

The stock market rallied on Thursday as it appears the mini 3% correction is over. As I’ve mentioned, there is a large group of investors who are dying to get into the market. Whenever there is a 5% correction, they plow money into stocks. Because 5% corrections have become rare, these bullish investors preempt them […]
French Presidential Election, Political Risk And Global Economic News

French Presidential Election, Political Risk And Global Economic News

On this week’s episode of Market Week in Review, Investment Strategist Paul Eitelman joins Sophie Antal-Gilbert, program director, advisor insights, to discuss both the French presidential election and UK snap election, as well as the week’s global economic news.
Stifel Tells Investors To Buy SeaWorld, Six Flags

Stifel Tells Investors To Buy SeaWorld, Six Flags

Research firm Stifel started coverage of several amusement park operators with Buy ratings, telling investors that SeaWorld (SEAS) should benefit from its strong management team, while Six Flags’ (SIX) valuation is attractive. SEAWORLD: Analyst Steven Wieczynski says that the stock has a better risk/reward ratio than any other theme park name he covers. The company’s […]
Agriculture Markets Report – Friday, April 21

Agriculture Markets Report – Friday, April 21

Video length: 00:11:08
Adamis Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock

Adamis Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock

SAN DIEGO, April 21, 2017 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy, announced today the pricing of its previously announced underwritten public offering of 4,285,715 shares of its common stock at a public offering price of […]
Dividend Aristocrat Cardinal Health Drops 12% – Buying Opportunity Or Value Trap?

Dividend Aristocrat Cardinal Health Drops 12% – Buying Opportunity Or Value Trap?

Cardinal Health (CAH) its guidance Tuesday morning, causing its stock price to plunge nearly 12% on the day. The company previously cut its profit guidance in October 2016, but today’s news was clearly still a big surprise. Many investors like owning dividend aristocrats such as Cardinal Heath because they have been less volatile than the broader market. […]
Being John Malkovich-Moment

Being John Malkovich-Moment

Do you remember the movie Being John Malkovich, the one where John Cusack and his girlfriend go into Malkovich’s brain? Then along the way John Malkovich goes into his own brain? Yeah, it was a weird movie but it was funny too. The ETF business may be having its own Being John Malkovich-moment with the launch […]
Most Active Stock Options For End Of Day – Friday, April 21

Most Active Stock Options For End Of Day – Friday, April 21

Most Active Stock Options For End Of Day April 21, 2017